Completed NA INTERVENTIONAL 3-arm NCT01324089

Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol

A Randomized, Double-Blind Pilot Trial of Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol

Sponsor: National Cancer Institute (NCI)

Conditions Focus of the Study: Normal Volunteers

Interventions Resveratrol Resveratrol 2.5 grams x 1 dose and Piperine 25 mg x 1 dose Resveratrol 2.5 grams x 1 dose and Piperine 5 mg x 1 dose

Updated 6 times since 2017 Last updated: Dec 12, 2019 Started: Mar 31, 2011 Primary completion: Nov 30, 2011 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Focus of the Study: Normal Volunteers and is currently completed. National Cancer Institute (NCI) leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Jan 2020 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
National Institutes of Health (NIH)
University of Wisconsin, Madison

Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madison, United States